Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: celeryroot.com who wrote (622)	8/9/1999 2:15:00 PM
From: John Dwyer	Read Replies (2) \| Respond to of 4474

If your point is that the short interest has increased over the last eight months, you are right. My point is that the shorts have plagued this stock for several years and that the current shorts are not necessarily the investors in the series C. I know many here on SI look for conspiracies with these smallcap stocks but the fact of the matter is that ARIA has failed to execute their signal transduction program, has yet to demonstrate value out of the Genomics Center, has not made a major partnership with the ARGENT technology and has floated what appears to be a toxic convertable offering... any short in his/her right mind would jump all over this. Oh, and did I mention possible delisting if the trading range dips below $1? I'm long on the stock, I've held a moderate position for several years and actually added a bit recently for trading purposes. I still believe the technology is worth more than the market cap but I don't know if that value will ever be realized. John